IRIS
Gennari, Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.681
NA - Nord America 5.249
AS - Asia 3.819
SA - Sud America 624
Continente sconosciuto - Info sul continente non disponibili 387
AF - Africa 132
OC - Oceania 10
Totale 15.902
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.077
RU - Federazione Russa 1.524
IT - Italia 1.150
SG - Singapore 1.088
IE - Irlanda 1.038
CN - Cina 858
VN - Vietnam 605
DE - Germania 588
HK - Hong Kong 557
BR - Brasile 442
SE - Svezia 379
UA - Ucraina 330
FR - Francia 247
BD - Bangladesh 185
GB - Regno Unito 147
IN - India 117
ID - Indonesia 100
CA - Canada 89
KR - Corea 85
AR - Argentina 67
BJ - Benin 58
FI - Finlandia 52
AT - Austria 45
NL - Olanda 44
MX - Messico 43
TR - Turchia 32
JP - Giappone 31
ES - Italia 30
IR - Iran 27
EC - Ecuador 26
PL - Polonia 26
PK - Pakistan 25
IQ - Iraq 23
LT - Lituania 21
ZA - Sudafrica 21
VE - Venezuela 20
CO - Colombia 19
BE - Belgio 18
PY - Paraguay 16
PE - Perù 14
CL - Cile 13
MA - Marocco 12
UZ - Uzbekistan 10
DZ - Algeria 9
AU - Australia 8
CZ - Repubblica Ceca 8
EG - Egitto 8
EU - Europa 8
JM - Giamaica 8
TH - Thailandia 8
KG - Kirghizistan 7
PH - Filippine 7
SA - Arabia Saudita 7
TT - Trinidad e Tobago 7
NP - Nepal 6
ET - Etiopia 5
KE - Kenya 5
LB - Libano 5
RO - Romania 5
TN - Tunisia 5
AZ - Azerbaigian 4
BO - Bolivia 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
HN - Honduras 4
KZ - Kazakistan 4
MY - Malesia 4
RS - Serbia 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CH - Svizzera 3
HU - Ungheria 3
JO - Giordania 3
MK - Macedonia 3
PT - Portogallo 3
BG - Bulgaria 2
CI - Costa d'Avorio 2
GR - Grecia 2
GT - Guatemala 2
GY - Guiana 2
HR - Croazia 2
IL - Israele 2
LK - Sri Lanka 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PA - Panama 2
PR - Porto Rico 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
CU - Cuba 1
DM - Dominica 1
GD - Grenada 1
GM - Gambi 1
KH - Cambogia 1
Totale 15.508
Salva come PNG Salva come JPEG
Città #
Dublin 1.032
Jacksonville 602
Hong Kong 553
San Jose 501
Council Bluffs 486
Singapore 483
Ashburn 396
Piemonte 373
Beijing 260
Dearborn 230
Moscow 210
Los Angeles 200
Columbus 164
Ho Chi Minh City 159
Lauterbourg 156
Lawrence 129
Princeton 129
Wilmington 127
Dong Ket 116
Chandler 97
Santa Clara 95
Hanoi 94
Buffalo 77
Seoul 77
Jakarta 76
New York 74
Milan 64
Novara 64
Cotonou 58
Dallas 54
Bremen 47
Nuremberg 47
Redondo Beach 47
São Paulo 47
Ann Arbor 46
San Mateo 45
Munich 43
Rome 41
Helsinki 38
Toronto 38
Falkenstein 34
Orem 34
Turin 33
Frankfurt am Main 32
Guangzhou 30
Tianjin 29
Phoenix 28
Amsterdam 25
Houston 25
Atlanta 23
Denver 23
London 23
Tokyo 23
Da Nang 22
Haiphong 22
Hangzhou 21
Boardman 20
Montreal 20
Vienna 20
Brooklyn 19
Mexico City 19
Shanghai 19
Warsaw 19
Chennai 18
Poplar 18
Shenzhen 18
Boston 17
Nanjing 17
Naples 17
Brussels 16
Biên Hòa 15
Rio de Janeiro 15
San Francisco 14
Andover 13
Ankara 13
Bologna 13
Chicago 13
Hefei 13
Norwalk 13
Strasbourg 13
Turku 13
Johannesburg 12
Monmouth Junction 12
Reggio Emilia 12
St Louis 12
Baghdad 10
Fairfield 10
Galliate 10
Kunming 10
Mumbai 10
Seattle 10
Stockholm 10
Bogotá 9
Brasília 9
Charlotte 9
Florence 9
Genoa 9
Manchester 9
Odalengo Grande 9
Quito 9
Totale 8.597
Salva come PNG Salva come JPEG
Nome #
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 263
A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study 238
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 204
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 193
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry 180
Metastatic mediastinal germ-cell tumor and concurrent COVID-19: when chemotherapy is not deferrable. 155
Case histories: breast cancer 153
Impact of Rehabilitation on Breast Cancer Related Fatigue: A Pilot Study 151
Adjuvant pertuzumab and trastuzumab in early her2-positive breast cancer 148
Time-Dependent COVID-19 Mortality in Patients with Cancer: An Updated Analysis of the OnCovid Registry 146
Axillary web syndrome in women after breast cancer surgery referred to an Oncological Rehabilitation Unit: which are the main risk factors? A retrospective case-control study 141
A randomized phase II study evaluating different maintenance schedules of nab-Paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial 137
Insulin-like Growth Factor-1 Receptor (IGF-1R) expression on Circulating Tumor Cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial 137
Bone health, vitamin D status and oral hygiene screening in breast cancer women before starting osteoporosis treatment: a cross-sectional study 136
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: The OnCovid Inflammatory Score 133
Efficacy and safety of antibody-drug conjugates in pretreated HER2-low metastatic breast cancer: A systematic review and network meta-analysis 130
Insulin/IGF Axis in Breast Cancer: Clinical Evidence and Translational Insights 130
Anthracyclines in the management of metastatic breast cancer: state of the art 128
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer 127
Presenting features and early mortality from SARS-CoV-2 infection in cancer patients during the initial stage of the COVID-19 pandemic in Europe 127
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry 127
[18F]FDG-PET/CT in adrenal lesions: diagnostic performance in different clinical settings 127
Aging and endothelial function in normotensive subjects and patients with essential hypertension 126
3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3) 125
Prevalence and impact of COVID-19 sequelae on treatment pathways and survival of patients with cancer who recovered from SARS-Cov-2 infection: results from the OnCovid registry. 125
3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3). 124
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients 123
A Simon's two-stage design trial evaluating the potential role of a kind of honey in preventing chemotherapy-hematopoietic toxicities 121
[Management of nausea and vomiting in cancer patients. Use of transdermal patches containing granisetron in patients affected by head and neck squamous-cell carcinoma] 121
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry 121
Breast Cancer Survivorship, Quality of Life and Late Toxicities 120
Weight Management Effectiveness and Predictors of Dropout in Breast Cancer Survivors: A Retrospective Study 119
An observational study of nasal cavity toxicity in cancer patients treated with bevacizumab 119
Curative Lung Metastasectomy Without Concomitant Androgen Deprivation Therapy in Oligometastatic Castration-resistant Prostate Cancer: A Case Report and Review of the Literature 118
HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support 115
Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries 114
18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT 114
Chemotherapy of non-small-cell lung cancer: Role of erythropoietin in the management of anemia 114
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial 113
Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy 112
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE). 111
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study 109
ERA-Net TRANSCAN JTC 2011: Critical aspects of the startup procedures of an International Academic Clinical trial (ET-FES), funded by the European Community (EC) and coordinated by an Italian Institution 107
Identification of a prognostic signature based on the expression of genes related to the insulin pathway in early breast cancer 106
Adjuvant chemotherapy in breast cancer. International perspective 105
Precision Medicine in Systemic Mastocytosis 105
Anthracycline-free therapy for HER2-amplified breast cancer 104
A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer 104
Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer 104
Stereotactic ablative radiotherapy for oligometastatic prostate cancer 103
Oncolytic virotherapy: new weapon for breast cancer treatment 103
Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer 102
Gestione di nausea e vomito nel paziente oncologico. Utilizzo di cerotti transdermici contenenti granisetron in paziente affetto da neoplasia del distretto cervico-cefalico 102
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma 101
Age influence on some aspects of cardiovascular adaptation to hypertension 101
A dose-finding study of epirubicin in combination with paclitaxel in the treatment of advanced breast cancer 100
Precision Medicine Approaches with Metabolomics and Artificial Intelligence 99
Dual block with lapatinib and trastuzumab versus single agent trastuzumab combined with chemotherapy as neoadjuvant treatment of HER2-positive breast cancer: a meta-analysis of randomized trials 99
Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry 95
Association of Biomarkers with Serious Cardiac Adverse Events during Abiraterone Acetate Treatment in Castration Resistant Prostate Cancer 95
Paclitaxel combinations as front-line and salvage chemotherapy regimens in advanced breast cancer 94
Phase II Study of Dehydroepiandrosterone in Androgen Receptor-Positive Metastatic Breast Cancer. 94
The gemcitabine/epirubicin/paclitaxel trials in advanced breast cancer 93
Comparative efficacy of novel combination strategies for unresectable hepatocellular carcinoma: A network metanalysis of phase III trials 92
Anthracyclines-paclitaxel combinations in the treatment of breast cancer 91
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study 90
Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial 89
Dose-finding study and pharmacokinetics of epirubicin and paclitaxel over 3 hours: A regimen with high activity and low cardiotoxicity in advanced breast cancer 89
Cardiotossicità da antracicline 89
Three-dimensional laser scanning as a reliable and reproducible diagnostic tool in breast cancer related lymphedema rehabilitation: a proof-of-principle study 89
Cardiotoxicity of epirubicin/paclitaxel-containing regimens: Role of cardiac risk factors 88
Early Assessment by PET with FDG of Response to First-Line Chemotherapy of Metastatic Breast Cancer 88
SARS-CoV-2 re-infection in a cancer patient with a defective neutralizing humoral response 88
Survival of metastatic breast carcinoma patients over a 20-year period - A retrospective analysis based on individual patient data from six consecutive studies 87
Implications of metabolism-driven myeloid dysfunctions in cancer therapy 87
New Understanding of the Role of Anthracyclines in Early-Stage Breast Cancer: Patient Selection Considerations 86
Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II study 86
Clinical activity and cardiac tolerability of non-pegylated liposomal doxorubicin in breast cancer: a synthetic review 86
Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial 86
Breast cancer "tailored follow-up" in Italian oncology units: a web-based survey 86
Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma 84
New combinations with epirubicin in advanced breast cancer 84
The quality of life issue in metastatic breast cancer 84
The science behind vitamins and natural compounds for breast cancer prevention. Getting the most prevention out of it. 84
Paclitaxel plus epirubicin in advanced breast cancer 83
Phenotypic Characteristics of the Tumour Microenvironment in Primary and Secondary Hepatocellular Carcinoma 83
Untargeted lipidomics reveal association of elevated plasma C18 ceramide levels with reduced survival in metastatic castration-resistant prostate cancer patients 82
Extending the duration of first-line chemotherapy in metastatic breast cancer: A perspective review 82
Apalutamide, darolutamide and enzalutamide for nonmetastatic castration-resistant prostate cancer (nmCRPC) 82
Bevacizumab and breast cancer: A meta-analysis of first-line phase III studies and a critical reappraisal of available evidence 81
Myelopoiesis, metabolism and therapy: a crucial crossroads in cancer progression. 80
Breast Cancer Diet "BCD": A Review of Healthy Dietary Patterns to Prevent Breast Cancer Recurrence and Reduce Mortality 80
Novel immunotherapy combinations in clinical trials for hepatocellular carcinoma: will they shape the future treatment landscape? 77
Lack of benefit of maintenance paclitaxel in first-line chemotherapy in metastatic breast cancer 77
Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review 76
Body mass index and prognosis of metastatic breast cancer patients receiving first-line chemotherapy 76
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer 76
Duration of Chemotherapy for Metastatic Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Clinical Trials 75
Paclitaxel and vinorelbine in anthracycline-pretreated breast cancer: A phase II study 75
Epirubicin plus low-dose trastuzumab in HER2 positive metastatic breast cancer 75
Totale 10.984
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.810
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.810
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022827 0 23 84 107 29 33 60 32 92 60 135 172
2022/20231.814 162 69 132 18 69 138 54 75 992 21 45 39
2023/2024756 90 29 53 26 128 17 126 17 19 13 52 186
2024/20252.045 28 26 140 31 53 138 255 214 607 193 76 284
2025/20266.988 294 238 458 895 623 503 943 1.091 489 654 506 294
2026/2027928 317 611 0 0 0 0 0 0 0 0 0 0
Totale 15.902